Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)

Details for Australian Patent Application No. 2002335770 (hide)

International Classifications

Event Publications

20 February 2003 Complete Application Filed

Priority application(s): 60/323,937 21.09.01 US

26 June 2003 Application Open to Public Inspection

Published as AU-B-2002335770

18 August 2005 Application Accepted

Published as AU-B-2002335770

22 December 2005 Application for Amendment

The nature of the amendment is: Add priority details 10/166,942 11 June 2002 US. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

6 April 2006 Amendment Made

The nature of the amendment is: Add priority details 10/166,942 11 Jun 2002 US 2002356992 Albert Einstein College of Medicine of Yeshiva University; The John Hopkins University The nature of the amendment is: Amend the name of the applicant from The John Hopkins University to The Johns Hopkins University

6 April 2006 Standard Patent Sealed

11 October 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.